Product NDC: | 51672-2016 |
Proprietary Name: | Triple Antibiotic |
Non Proprietary Name: | Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate |
Active Ingredient(s): | 400; 3.5; 5000 [iU]/g; mg/g; [iU]/g & nbsp; Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-2016 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part333B |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 19951214 |
Package NDC: | 51672-2016-1 |
Package Description: | 1 TUBE in 1 CARTON (51672-2016-1) > 14.2 g in 1 TUBE |
NDC Code | 51672-2016-1 |
Proprietary Name | Triple Antibiotic |
Package Description | 1 TUBE in 1 CARTON (51672-2016-1) > 14.2 g in 1 TUBE |
Product NDC | 51672-2016 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 19951214 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
Strength Number | 400; 3.5; 5000 |
Strength Unit | [iU]/g; mg/g; [iU]/g |
Pharmaceutical Classes |